Texas Sues Johnson & Johnson, Kenvue Over Tylenol's Alleged Autism Risk Marketing to Pregnant Women
Texas AG Ken Paxton sues Johnson & Johnson and Kenvue, alleging deceptive Tylenol marketing to pregnant women, claiming autism risk despite medical expert disputes.
MSNBCTexas sues Tylenol makers over disproven claims about autism
PBS NewsHourLawsuit by Trump ally Paxton asserts unproven claim of autism risk from acetaminophen
The GuardianTexas sues Tylenol makers alleging deceptive marketing to pregnant people
ARS TechnicaIf things in America weren’t stupid enough, Texas is suing Tylenol maker
Overview
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging deceptive marketing of Tylenol to pregnant women, claiming it increases autism risk.
The lawsuit asserts companies promoted Tylenol as the only safe painkiller for pregnant women, despite alleged knowledge of potential risks to fetuses and young children.
This legal action aligns with warnings from President Trump and HHS Secretary Kennedy Jr. about Tylenol's autism link, though medical experts widely dispute these claims.
Paxton also alleges Johnson & Johnson fraudulently transferred Tylenol liabilities to Kenvue in 2023 to protect assets from lawsuits, violating Texas law.
Texas seeks $10,000 per violation under consumer protection laws and demands destruction of marketing materials claiming Tylenol's safety for pregnant women.
Analysis
Center-leaning sources frame the Texas lawsuit against Tylenol companies by consistently highlighting the "unproven" nature of the autism link claims. They emphasize the lack of scientific consensus supporting the allegations, often presenting this information early and prominently. This editorial choice shapes the narrative to cast doubt on the lawsuit's scientific basis, prioritizing the perspective that acetaminophen is safe for pregnant women.